Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06074133 · ClinicalTrials.gov registry record

A Combined Biomarker Model for Risk Stratification of Indeterminate Pulmonary Nodules

A clinical trial of Pulmonary Nodule, sponsored by Vanderbilt-Ingram Cancer Center.

Recruiting
Registry status
100
Enrollment target
4
Study locations

NCT06074133 is a study of Pulmonary Nodule that is actively recruiting participants, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 100 participants, below the 338-participant average among 4 other Pulmonary Nodule trials with a reported enrollment target (70% lower). The trial reports 4 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06074133, a study of Pulmonary Nodule, is actively recruiting participants, sponsored by Vanderbilt-Ingram Cancer Center.

RECRUITING
Registry status
100 participants
Enrollment target
4
Study locations

Study Summary

This is a prospective, multicenter observational study aim at estimating the potential clinical utility of the CBM and at establishing the SOPs and protocols for a future randomized control trial.

Conditions Studied

Interventions

  • PROCEDURE Blood collection
  • PROCEDURE Chest Computed Tomography

Study Locations (4)

Colorado

  • Rocky Mountain Regional VA Medical Center - Aurora
  • University of Colorado - Aurora

Tennessee

  • Vanderbilt University/Ingram Cancer Center - Nashville
  • VA Tennessee Valley Healthcare Center - Nashville

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2024-03-07
Est. Completion 2029-03-31

Sponsor

Vanderbilt-Ingram Cancer Center

189 total trials

What the Registry Record Tells You About NCT06074133

The ClinicalTrials.gov registry entry for NCT06074133 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 338-participant average among 4 other Pulmonary Nodule trials with a reported enrollment target (70% lower). The listed sponsor is Vanderbilt-Ingram Cancer Center, which has 189 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pulmonary Nodule appearing as the primary indexed condition, and to 2 interventions - of which Blood collection is the first listed.

NCT06074133 reports 4 study locations spanning 2 distinct geographic areas - top geographies include Colorado, Tennessee.

Frequently Asked Questions

What is clinical trial NCT06074133 about?

NCT06074133 is a clinical study titled "A Combined Biomarker Model for Risk Stratification of Indeterminate Pulmonary Nodules". This is a prospective, multicenter observational study aim at estimating the potential clinical utility of the CBM and at establishing the SOPs and protocols for a future randomized control trial.

What is the current status of trial NCT06074133?

This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2024-03-07. Estimated completion is 2029-03-31.

What conditions does trial NCT06074133 study?

This clinical trial studies the following conditions: Pulmonary Nodule.

What interventions are being tested in trial NCT06074133?

The interventions under investigation include: Blood collection (PROCEDURE), Chest Computed Tomography (PROCEDURE).

Who is sponsoring clinical trial NCT06074133?

This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06074133 being conducted?

This trial has 4 study locations across Colorado, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pulmonary Nodule

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.